Literature DB >> 18504100

Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation.

V van Weel1, R B van Tongeren, V W M van Hinsbergh, J H van Bockel, P H A Quax.   

Abstract

Stimulation of vascular growth to treat limb ischemia is promising, and early results obtained from uncontrolled clinical trials using angiogenic agents, e.g., vascular endothelial growth factor, led to high expectations. However, negative results from recent placebo-controlled trials warrant further research. Here, current insights into mechanisms of vascular growth in the adult, in particular the role of angiogenic factors, the immune system, and bone marrow, were reviewed, together with modes of its therapeutic stimulation and results from recent clinical trials. Three concepts of vascular growth have been described to date-angiogenesis, vasculogenesis, and arteriogenesis (collateral artery growth)-which represent different aspects of an integrated process. Stimulation of arteriogenesis seems clinically most relevant and has most recently been attempted using autologous bone marrow transplantation with some beneficial results, although the mechanism of action is not completely understood. Better understanding of the highly complex molecular and cellular mechanisms of vascular growth may yet lead to meaningful clinical applications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18504100     DOI: 10.1016/j.avsg.2008.02.017

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  33 in total

1.  Long-term Angiogenesis Efficacy Using a Heparin-Conjugated Fibrin (HCF) Delivery System with HBM-MSCs.

Authors:  Ae-Kyeong Kim; Min-Hee Kim; Byung-Soo Kim; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2012-05       Impact factor: 2.500

2.  Polymerase δ-interacting protein 2 promotes postischemic neovascularization of the mouse hindlimb.

Authors:  Angélica M Amanso; Bernard Lassègue; Giji Joseph; Natalia Landázuri; James S Long; Daiana Weiss; W Robert Taylor; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-22       Impact factor: 8.311

3.  Epigenetic regulators of the revascularization response to chronic arterial occlusion.

Authors:  Joshua L Heuslein; Catherine M Gorick; Richard J Price
Journal:  Cardiovasc Res       Date:  2019-03-15       Impact factor: 10.787

4.  Tunable delivery of siRNA from a biodegradable scaffold to promote angiogenesis in vivo.

Authors:  Christopher E Nelson; Arnold J Kim; Elizabeth J Adolph; Mukesh K Gupta; Fang Yu; Kyle M Hocking; Jeffrey M Davidson; Scott A Guelcher; Craig L Duvall
Journal:  Adv Mater       Date:  2013-12-16       Impact factor: 30.849

5.  T-cadherin is essential for adiponectin-mediated revascularization.

Authors:  Jennifer L Parker-Duffen; Kazuto Nakamura; Marcy Silver; Ryosuke Kikuchi; Ulrich Tigges; Sumiko Yoshida; Martin S Denzel; Barbara Ranscht; Kenneth Walsh
Journal:  J Biol Chem       Date:  2013-07-03       Impact factor: 5.157

6.  Despite normal arteriogenic and angiogenic responses, hind limb perfusion recovery and necrotic and fibroadipose tissue clearance are impaired in matrix metalloproteinase 9-deficient mice.

Authors:  Joshua K Meisner; Brian H Annex; Richard J Price
Journal:  J Vasc Surg       Date:  2014-02-28       Impact factor: 4.268

Review 7.  Pharmacotherapy for end-stage coronary artery disease.

Authors:  Neel R Sodha; Louis M Chu; Munir Boodhwani; Frank W Sellke
Journal:  Expert Opin Pharmacother       Date:  2010-02       Impact factor: 3.889

8.  Bioartificial matrices for therapeutic vascularization.

Authors:  Edward A Phelps; Natalia Landázuri; Peter M Thulé; W Robert Taylor; Andrés J García
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-31       Impact factor: 11.205

9.  Limited value of digital subtraction angiography in the evaluation of cell-based therapy in patients with limb ischemia.

Authors:  Robert B van Tongeren; Jaap F Hamming; Saskia le Cessie; Arian R van Erkel; J Hajo van Bockel
Journal:  Int J Cardiovasc Imaging       Date:  2009-09-16       Impact factor: 2.357

Review 10.  Update on therapeutic vascularization strategies.

Authors:  Edward A Phelps; Andres J Garcia
Journal:  Regen Med       Date:  2009-01       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.